TrialAdvances in therapy2026

Efficacy and Safety of Ravagalimab in Patients with Moderate-to-Severe Ulcerative Colitis: Data from a Phase 2a Trial.

Laurent Peyrin-Biroulet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.